Aspartic acid
Aspartic acid carries a short carboxyl side chain that is deprotonated and negative at any ordinary pH. It is the most acidic of the twenty, and its compactness makes it both a precise binding partner and a stability risk.
- Molecular formula
- C4H7NO4
- Molar mass
- 133.1 g/mol
- Residue mass, average
- 115.0886 Da
- Residue mass, monoisotopic
- 115.02694 Da
- pKa (α-COOH / α-NH₃⁺)
- 1.88 / 9.6
- Side-chain pKa
- 3.65
- Isoelectric point
- 2.77
- CAS number
- 56-84-8
Structure
- H
- C
- N
- O
- S
The 3D geometry represents the neutral experimental record; the pH control applies to the skeletal view.
The skeletal view begins with the zwitterion at pH 7.
An acid with a low pKa
The side-chain carboxyl has a pKa near 3.65, so above pH 5 it is essentially fully deprotonated. In a peptide at pH 7 an aspartate position reliably carries a negative charge.
Short and precise
A single methylene separates the carboxylate from the backbone, so the charge sits close in and cannot reach far. That precision is useful in metal binding sites, where geometry matters more than reach.
Charge and pH
Three steps, a low isoelectric point
Two acidic groups and one basic group give aspartic acid an isoelectric point of 2.77, the lowest of the twenty alongside glutamic acid. It is negatively charged everywhere above pH 4.
Effect on a peptide
Each aspartate pulls the isoelectric point of a peptide down. A sequence rich in aspartate and glutamate will be soluble at neutral pH and may precipitate if the pH is dropped towards its pI.
Properties
| IUPAC name | (2S)-2-aminobutanedioic acid |
|---|---|
| Three-letter code | Asp |
| One-letter code | D |
| Class | Negatively charged |
| Dietary requirement | Non-essential |
| CAS | 56-84-8 |
| PubChem CID | 5960 |
| InChIKey | CKLJMWTZIZZHCS-REOHCLBHSA-N |
| Formula | C4H7NO4 |
|---|---|
| Molar mass | 133.1 g/mol |
| Residue mass, average | 115.0886 Da |
| Residue mass, monoisotopic | 115.02694 Da |
| Side chain | −CH₂COO⁻ |
| pKa, α-carboxyl | 1.88 |
| pKa, α-amino | 9.6 |
| pKa, side chain | 3.65 |
| Isoelectric point | 2.77 |
| Hydropathy | -3.5 |
| Volume ų | 91 |
Genetic code and occurrence
Codons
- GAU
- GAC
Codons are written as mRNA; U is uracil.
| Frequency in proteins | 5.45% |
|---|---|
| Number of codons | 2 |
| Dietary requirement | Non-essential |
Role in peptides
Isomerisation
Aspartate followed by glycine can cyclise and rearrange into isoaspartate, which inserts an extra carbon into the backbone. The mass does not change, so the problem hides from a simple mass check.
Metal coordination
Carboxylate oxygens are good ligands for calcium, magnesium and zinc. Clusters of aspartate and glutamate are the standard way that proteins grip a metal ion.
Salt bridges
Paired with arginine or lysine, aspartate forms the ionic contacts that hold many folds and binding interfaces together.
Biological role
Nitrogen transfer
Aspartate carries nitrogen into the urea cycle and into purine and pyrimidine synthesis. It is made from oxaloacetate in a single transamination, so it is never in short supply.
Catalysis
Aspartic proteases such as pepsin and renin use a pair of aspartate residues to activate a water molecule. HIV protease works the same way, which is how its inhibitors were designed.
D-aspartate
Unusually for a D-amino acid, D-aspartate occurs naturally in the brain and in endocrine tissue, where it appears to have a signalling role. It is distinct from the L form used to build proteins.
Aspartame
The sweetener is a methyl ester of aspartyl-phenylalanine. It is broken down to those two residues plus methanol during digestion, which is why it carries a warning for people with phenylketonuria.
Research evidence
| Area | Summary | Evidence |
|---|---|---|
| D-aspartate and testosterone | Small trials of D-aspartic acid supplementation reported a short-lived rise in testosterone in some untrained men, and later trials in trained men found no benefit or a decrease. The literature is small and contradictory. | Contested |
| Aspartame safety | Aspartame is among the most studied food additives. Regulators have repeatedly judged approved intakes acceptable, while a 2023 hazard classification prompted renewed debate. The dispute concerns the sweetener, not the residue. | Contested |
| Aspartate as a supplement | L-aspartic acid itself has little human supplement literature; it is plentiful in dietary protein and no deficiency state is described. | Not studied |
These summaries describe research on amino acids and related molecules, not evidence for Aminos products. Aminos products are laboratory research reagents, not supplements or medicines.
Laboratory notes
Isoaspartate formation
The Asp-Gly sequence is the main isomerisation risk. Because isoaspartate has the same mass as aspartate, it needs a separation method or a specific assay to detect.
Acid-catalysed cleavage
Asp-Pro bonds are unusually labile in acid. Peptides containing that pair can fragment during cleavage or in acidic storage.
Anion exchange
Aspartate-rich peptides bind anion exchange media at neutral pH and are eluted with salt or by dropping the pH.
Solubility near the pI
A peptide dominated by acidic residues is least soluble near its low isoelectric point. Moving a formulation a pH unit or two away from it usually fixes an unexplained precipitation.
References
Sources used for the data on this page.
- PubChem CID 5960: L-Aspartic acidIdentifiers, formula and physical data.
- pKa and pI values for the twenty amino acidsDepartment of Chemistry, University of Calgary.
Reference information only. This page describes the chemistry and biology of an amino acid. Nothing here is medical, nutritional or dosing advice. Aminos compounds are sold strictly for laboratory research use and are not medicines.